Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

UK's NICE Recommends Use Of Erbitux For Metastatic Colorectal Cancer Patients
The United Kingdom"s National Institute for Health and Clinical Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending the use of the drug Erbitux® (cetuximab) in combination with chemotherapy as a 1st-line treatment for patients with metastatic (advanced) colorectal cancer (mCRC) who have met specific additional criteria1 - presenting the possibility of potentially curative surgery.2 The treatment is recommended for patients in whom the cancer has spread only to the liver and who have normal or "wild-type" KRAS tumors.1 In the UK, a recommendation by NICE is a prerequisite for funding of a medical treatment by the National Health Service.
generic viagra online
Vanderbilt Researchers Pioneer An Advanced Sepsis Detection And Management System
When Jason Martin gives a talk about his research, he begins with the dramatic story of Mariana Bridi da Costa: The young Brazilian supermodel died from severe sepsis in January after amputation of both her hands and feet failed to stop its spread.
News of the day
Abbott's TRILIPIX® (fenofibric Acid) In Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia And Type 2 Diabetes Meet Amer
Abbott"s (NYSE: ABT) TRILIPIX® (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium achieved individual and combined lipid targets in patients with mixed dyslipidemia and type 2 diabetes. In these patients, the combination of TRILIPIX and rosuvastatin helped up to three times more patients simultaneously reach all three key lipid targets HDL, triglycerides and LDL than the pre-determined monotherapy. Results from this post-hoc analysis were presented at the American Diabetes Association"s 2009 Scientific Sessions.
Nutrition

Expert On College Alcohol Abuse And Prevention Available To Speak On New Study

A report released by the U.S. National Institute on Alcohol Abuse and Alcoholism found that binge drinking and drinking-related deaths among college-age students are increasing. Kitty Harris-Wilkes, director of Texas Tech University"s Center for the Study of Addiction and Recovery, can speak about drug and alcohol abuse among college students and prevention methods that could help curb these trends. The Center for the Study of Addiction and Recovery is the country"s largest and one of the oldest campus recovery communities. It uses a peer-support system to help students recovering from drug and alcohol addictions and even issues such as gambling and eating disorders navigate the treacherous landscape of a college campus. Dynamic and extremely personable, Harris-Wilkes has first-hand experience working with hundreds of college students who have managed to overcome drug and alcohol addictions. During the past 20 years, more than 500 students have graduated through the center with a collective GPA of more than 3.3 and only 7 percent of active participants suffered relapses. The program has been so successful that Harris-Wilkes has overseen or advised the development of similar programs at schools such as the University of Texas, Ole Miss and Georgia Southern University. She also has created a curriculum model that is being distributed nationally. Center researchers have amassed a body of research on the processes and factors involved in young adult addiction and recovery. Texas Tech University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009